The DOI matches its Crossref record; 264 of the 264 references it cites were found in a registry or an index.
p53 Acetylation: Regulation and Consequences
Open accessAbstract
Post-translational modifications of p53 are critical in modulating its tumor suppressive functions. Ubiquitylation, for example, plays a major role in dictating p53 stability, subcellular localization and transcriptional vs. non-transcriptional activities. Less is known about p53 acetylation. It has been shown to govern p53 transcriptional activity, selection of growth inhibitory vs. apoptotic gene targets, and biological outcomes in response to diverse cellular insults. Yet recent in vivo evidence from mouse models questions the importance of p53 acetylation (at least at certain sites) as well as canonical p53 functions (cell cycle arrest, senescence and apoptosis) to tumor suppression. This review discusses the cumulative findings regarding p53 acetylation, with a focus on the acetyltransferases that modify p53 and the mechanisms regulating their activity. We also evaluate what is known regarding the influence of other post-translational modifications of p53 on its acetylation, and conclude with the current outlook on how p53 acetylation affects tumor suppression. Due to redundancies in p53 control and growing understanding that individual modifications largely fine-tune p53 activity rather than switch it on or off, many questions still remain about the physiological importance of p53 acetylation to its role in preventing cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–264 of 264
New p53 related genes in human tumors: significant downregulation in colon and lung carcinomas
LLeonart, M. E., Vidal, F., Gallardo, D., Díaz-Fuertes, M., Rojo, F., Cuatrecasas, M., López-Vicente, L., Kondoh, H., Blanco, C., Carnero, A., et al. (2006) · Oncology Reports · doi:10.3892/or.16.3.603 · Cited by 103
Rokudai, S., Aikawa, Y., Tagata, Y., Tsuchida, N., Taya, Y., & Kitabayashi, I. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m805101200 · Cited by 102
HDAC6 promotes hepatocellular carcinoma progression by inhibiting P53 transcriptional activity
Ding, G., Liu, H., Huang, Q., Liang, H., Ding, Z.-H., Liao, Z., & Huang, G. (2013) · FEBS Letters · doi:10.1016/j.febslet.2013.02.001 · Cited by 100
Specific Acetylation of p53 by HDAC Inhibition Prevents DNA Damage-Induced Apoptosis in Neurons
Brochier, C., Dennis, G., Rivieccio, M. A., McLaughlin, K., Coppola, G., Ratan, R. R., & Langley, B. C. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.5214-12.2013 · Cited by 100
Love, I. M., Šekaric, P., Shi, D., Grossman, S. R., & Androphy, E. J. (2012) · Cell Cycle · doi:10.4161/cc.20864 · Cited by 98
Jiang, D., Brady, C. A., Johnson, T. M., Lee, E. Y., Park, E. J., Scott, M. P., & Attardi, L. D. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1111245108 · Cited by 95
TRIM29 negatively regulates p53 via inhibition of Tip60
Sho, T., Tsukiyama, T., Sato, T. Z., Kondo, T., Cheng, J., Saku, T., Asaka, M., & Hatakeyama, S. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2011.03.018 · Cited by 94
Lysine-specific modifications of p53: a matter of life and death?
Marouco, D. M., Garabadgiu, A. V., Melino, G., & Barlev, N. A. (2013) · Oncotarget · doi:10.18632/oncotarget.1436 · Cited by 93
Huang, J., Yang, J., Maity, B., Mayuzumi, D., & Fisher, R. A. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3397 · Cited by 92
Identification and Characterization of a Novel p300-mediated p53 Acetylation Site, Lysine 305
Wang, Y.-H., Tsay, Y.-G., Tan, B. C.-M., Lo, W.-Y., & Lee, S.-C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212574200 · Cited by 92
The Methyltransferase Set7/9 (Setd7) Is Dispensable for the p53-Mediated DNA Damage Response In Vivo
Campaner, S., Spreafico, F., Burgold, T., Doni, M., Rosato, U., Amati, B. B., & Testa, G. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.08.007 · Cited by 89
Interferon Regulatory Factor 1 Binding to p300 Stimulates DNA-Dependent Acetylation of p53
Dornan, D., Eckert, M. J., Wallace, M., Shimizu, H., Ramsay, E., Hupp, T. R., & Ball, K. L. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.22.10083-10098.2004 · Cited by 88
Deubiquitination of Tip60 by USP7 determines the activity of the p53-dependent apoptotic pathway.
Dar, A., Shibata, E., & Dutta, A. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.00358-13 · Cited by 83
Romanov, V. S., Igotti, M. V., Svetlikova, S. B., Bykova, T. V., Zubova, S. G., Aksenov, N. D., Fornace, A. J., Pospelova, T. V., & Pospelov, V. A. (2010) · Cell Cycle · doi:10.4161/cc.9.19.13160 · Cited by 83
Katsumoto, T., Yoshida, N., & Kitabayashi, I. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2008.00865.x · Cited by 79
Stefano, V. D., Soddu, S., Sacchi, A., & D’Orazi, G. (2005) · Oncogene · doi:10.1038/sj.onc.1208717 · Cited by 78
p53-Dependent Transcription and Tumor Suppression Are Not Affected in Set7/9-Deficient Mice
Lehnertz, B., Rogalski, J. C., Schulze, F. M., Yi, L., Lin, S., Kast, J., & Rossi, F. M. V. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.08.006 · Cited by 76
Cell Cycle Regulation of the Transcriptional Coactivators p300 and CREB Binding Protein
Snowden, A. W., & Perkins, N. D. (1998) · Biochemical Pharmacology · doi:10.1016/s0006-2952(98)00020-3 · Cited by 75
Dumaz, N., Milne, D., Jardine, L., & Meek, D. W. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3590459 · Cited by 75
Xu, L., Chen, Y., Song, Q., Xu, D. M., Wang, Y., & Ma, D. (2009) · Neoplasia · doi:10.1593/neo.81524 · Cited by 74
Jenkins, L. M. M., Yamaguchi, H., Hayashi, R., Cherry, S., Tropea, J. E., Miller, M., Wlodawer, A., Appella, E., & Mazur, S. J. (2009) · Biochemistry · doi:10.1021/bi801716h · Cited by 74
The WTX Tumor Suppressor Enhances p53 Acetylation by CBP/p300
Kim, W. J., Rivera, M. N., Coffman, E. J., & Haber, D. A. (2012) · Molecular Cell · doi:10.1016/j.molcel.2011.12.025 · Cited by 72
ING5 Is a Tip60 Cofactor That Acetylates p53 in Response to DNA Damage
Liu, N., Wang, J., Wang, J., Wang, R., Liu, Z., Yu, Y., & Lü, H. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3684 · Cited by 72
Illuminating p53 function in cancer with genetically engineered mouse models
Garcia, P. B., & Attardi, L. D. (2014) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2013.12.014 · Cited by 69
Inhibition of p53 acetylation by INHAT subunit SET/TAF-Iβ represses p53 activity
Kim, J.-Y., Lee, K., Seol, J.-E., Yu, K., Chakravarti, D., & Seo, S. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr614 · Cited by 69
MDM2 Mediates p300/CREB-binding Protein-associated Factor Ubiquitination and Degradation
Jin, Y., Zeng, S. X., Lee, H., & Lu, H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m309916200 · Cited by 68
Making sense of ubiquitin ligases that regulate p53
Jain, A. K., & Barton, M. C. (2010) · Cancer Biology & Therapy · doi:10.4161/cbt.10.7.13445 · Cited by 66
Role of Tip60 in Human Melanoma Cell Migration, Metastasis, and Patient Survival
Chen, G., Cheng, Y., Tang, Y., Martinka, M., & Li, G. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.193 · Cited by 65
MDMX inhibits the p300/CBP-mediated acetylation of p53
Sabbatini, P., & McCormick, F. (2002) · DNA and Cell Biology · doi:10.1089/104454902320219077 · Cited by 62
Janus, F., Albrechtsen, N., Knippschild, U., Wiesmüller, L., Große, F., & Deppert, W. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.3.2155 · Cited by 62
Buschmann, T., Adler, V., Matusevich, E., Fuchs, S. Y., & Ronai, Z. A. (2000) · PubMed · Cited by 62
Severe ocular abnormalities in C57BL/6 but not in 129/Sv p53-deficient mice.
Ikeda, S., Hawes, N. L., Chang, B., Avery, C., Smith, R. S., & Nishina, P. M. (1999) · PubMed · Cited by 60
PIASy-mediated Tip60 sumoylation regulates p53-induced autophagy
Naidu, S. R., Lakhter, A. J., & Androphy, E. J. (2012) · Cell Cycle · doi:10.4161/cc.21091 · Cited by 58
Mechanistic Studies of MDM2-mediated Ubiquitination in p53 Regulation
Brooks, C. L., Li, M., & Gu, W. J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700961200 · Cited by 56
Acetylation is indispensable for p53 antiviral activity
Muñoz‐Fontela, C., de Llano, D. G., Marcos-Villar, L., Campagna, M., Gallego, P. P. F., González, J., Herranz, D., Gu, W. J., Serrano, M., Aaronson, S. A., et al. (2011) · Cell Cycle · doi:10.4161/cc.10.21.17899 · Cited by 53
Huang, J., Stewart, A., Maity, B., et al. (2013) · Oncogene · doi:10.1038/onc.2013.324 · Cited by 53
Differential effects on p53-mediated cell cycle arrest vs. apoptosis by p90
Dai, C., Tang, Y., Jung, S. Y., Qin, J., Aaronson, S. A., & Gu, W. J. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1110988108 · Cited by 51
Hayes, V. M., Dirven, C. M. F., Dam, A., Verlind, E., Molenaar, W. M., Mooij, J. J. A., Hofstra, R. M. W., & Buys, C. H. C. M. (1999) · Brain Pathology · doi:10.1111/j.1750-3639.1999.tb00535.x · Cited by 51
Down-regulation of Tip60 gene as a potential marker for the malignancy of colorectal cancer.
Sakuraba, K., Yasuda, T., 坂田, 真., Kitamura, Y.-H., Shirahata, A., Goto, T., Mizukami, H., Saito, M., Ishibashi, K., Kigawa, G., et al. (2009) · PubMed · Cited by 50
p53 Mutations in Benign Prostatic Hyperplasia
Meyers, F. J., Chi, S.-G., Fishman, J. R., White, R. D., & Gumerlock, P. H. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.22.1856 · Cited by 48
Ying, M., Wang, J., Li, D., Yu, G. Z., Wang, X., Pan, J., Chen, Y., & He, M. (2010) · Cancer Biology & Therapy · doi:10.4161/cbt.9.4.10748 · Cited by 45
TIP60 as a potential marker for the malignancy of gastric cancer.
Sakuraba, K., Yokomizo, K., Shirahata, A., Goto, T., Saito, M., Ishibashi, K., Kigawa, G., Nemoto, H., & Hibi, K. (2011) · PubMed · Cited by 45
Specific inhibition of Mdm2-mediated neddylation by Tip60
Dohmesen, C., Koeppel, M., & Dobbelstein, M. (2008) · Cell Cycle · doi:10.4161/cc.7.2.5185 · Cited by 43
A Novel Nuclear Interactor of ARF and MDM2 (NIAM) That Maintains Chromosomal Stability
Tompkins, V. S., Hagen, J., Frazier, A. A., Lushnikova, T., Fitzgerald, M. P., Tommaso, A. D., Ladevèze, V., Domann, F. E., Eischen, C. M., & Quelle, D. E. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m609612200 · Cited by 42
Self-citationZhu, Q., Wani, G., Wani, M. A., & Wani, A. A. (2001) · PubMed · Cited by 41
Tumor Suppression by p53: Fall of the Triumvirate?
Hock, A. K., & Vousden, K. H. (2012) · Cell · doi:10.1016/j.cell.2012.05.024 · Cited by 41
Perez, R. E., Knights, C. D., Sahu, G., Catania, J., Kolukula, V. K., Stoler, D. L., Graessmann, A., Ogryzko, V. V., Pishvaian, M. J., Albanese, C., et al. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22285 · Cited by 40
Effect of Phosphorylation on the Structure and Fold of Transactivation Domain of p53
Kar, S., Sakaguchi, K., Shimohigashi, Y., Samaddar, S., Banerjee, R., Basu, G., Swaminathan, V., Kundu, T. K., & Roy, S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m106915200 · Cited by 39
Dai, C., Shi, D., & Gu, W. J. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.476606 · Cited by 38
Kasper, L. H., Thomas, M. C., Zambetti, G. P., & Brindle, P. K. (2011) · Cell Cycle · doi:10.4161/cc.10.2.14542 · Cited by 38
Zhao, H., Jin, S., & Gewirtz, A. M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.279950 · Cited by 38
Conservation of all three p53 family members and Mdm2 and Mdm4 in the cartilaginous fish
Lane, D. P., Madhumalar, A., Lee, A., Tay, B.-H., Verma, C. S., Brenner, S., & Venkatesh, B. (2011) · Cell Cycle · doi:10.4161/cc.10.24.18567 · Cited by 35
Nuclear interactor of ARF and Mdm2 regulates multiple pathways to activate p53
Reed, S. M., Hagen, J., Tompkins, V. S., Thies, K., Quelle, F. W., & Quelle, D. E. (2014) · Cell Cycle · doi:10.4161/cc.28202 · Cited by 34
Self-citationGrishina, I., Debus, K., García-Limones, C., Schneider, C., Shresta, A., García, C., Calzado, M. A., & Schmitz, M. L. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2012.09.011 · Cited by 33
The ARF/Oncogene Pathway Activates p53 Acetylation within the DNA Binding Domain
Mellert, H. S., Sykes, S. M., Murphy, M. E., & McMahon, S. B. (2007) · Cell Cycle · doi:10.4161/cc.6.11.4343 · Cited by 32
Song, L., Gao, M., Dong, W., Hu, M., Li, J., Shi, X., Hao, Y., Li, Y., & Huang, C. (2010) · Oncogene · doi:10.1038/onc.2010.506 · Cited by 29
Using Mouse Models to Explore MDM-p53 Signaling in Development, Cell Growth, and Tumorigenesis
Gannon, H., & Jones, S. N. (2012) · Genes & Cancer · doi:10.1177/1947601912455324 · Cited by 27
p53 can promote mitochondria- and caspase-independent apoptosis
Godefroy, N., Lemaire, C., Renaud, F., Rincheval, V., Pérez, S. C., Ferecatu, I., Mignotte, B., & Vayssière, J.-L. (2004) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401398 · Cited by 26
Lessons from interconnected ubiquitylation and acetylation of p53: think metastable networks
Benkirane, M., Sardet, C., & Coux, O. (2010) · Biochemical Society Transactions · doi:10.1042/bst0380098 · Cited by 24
S100A6 Competes with the TAZ2 Domain of p300 for Binding to p53 and Attenuates p53 Acetylation
Graczyk‐Jarzynka, A., Słomnicki, Ł. P., & Leśniak, W. (2013) · Journal of Molecular Biology · doi:10.1016/j.jmb.2013.06.007 · Cited by 21
Deißler, H., Kafka, A., Schuster, E., Sauer, G., Kreienberg, R., & Zeillinger, R. (2004) · Oncology Reports · doi:10.3892/or.11.6.1281 · Cited by 20
Induction of ASAP (MAP9) contributes to p53 stabilization in response to DNA damage
Basbous, J., Knani, D., Bonneaud, N., Giorgi, D., Brondello, J., & Rouquier, S. (2012) · Cell Cycle · doi:10.4161/cc.20858 · Cited by 17
Engaging the p53 metabolic brake drives senescence
Jiang, D., & Attardi, L. D. (2013) · Cell Research · doi:10.1038/cr.2013.34 · Cited by 13
Ubiquitin E3 ligases controlling p53 stability
Lee, S. W., Seong, M. W., Jeon, Y. J., & Chung, C. H. (2012) · Animal Cells and Systems · doi:10.1080/19768354.2012.688769 · Cited by 9
Cited by
Functions and mechanisms of non-histone protein acetylation
Narita, T., Weinert, B. T., & Choudhary, C. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0081-3 · Cited by 1,232
The tumor suppressor protein p53 and the ferroptosis network
Kang, R., Kroemer, G., & Tang, D. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.05.074 · Cited by 698
DNA damage responses and p53 in the aging process
Ou, H.-L., & Schumacher, B. (2018) · Blood · doi:10.1182/blood-2017-07-746396 · Cited by 377
p53 modifications: exquisite decorations of the powerful guardian
Liu, Y., Tavana, O., & Gu, W. (2019) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjz060 · Cited by 392
Syncytiotrophoblast stress in preeclampsia: the convergence point for multiple pathways
Redman, C. W. G., Staff, A. C., & Roberts, J. M. (2022) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2020.09.047 · Cited by 399
Metadata
- Authors
- Reed, S., & Quelle, D.
- Venue
- Cancers
- Publisher
- MDPI AG
- Published
- 2014-12-23
- Volume
- 7
- Issue
- 1
- Pages
- 30-69
- ISSN
- 2072-6694 (ISSN-L)
- OpenAlex
- W1988877971
- Cited by
- 332
- References
- 264
- FWCI
- 8.47
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.